Related Experiment Video
Updated: Jun 21, 2026
04:36
An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
Published on: January 12, 2024
Circulating beta-carotene levels and type 2 diabetes-cause or effect?
J R B Perry1, L Ferrucci, S Bandinelli
1Peninsula Medical School, Exeter, UK.
Diabetologia
|August 8, 2009
Summary
This Mendelian randomization study found no causal link between beta-carotene levels and type 2 diabetes risk. Findings suggest beta-carotene is not causally protective against type 2 diabetes, aligning with clinical trial results.
Area of Science:
- Nutritional Epidemiology
- Genetic Epidemiology
- Metabolic Disease Research
Background:
- Observational studies suggest an inverse association between circulating beta-carotene and type 2 diabetes risk.
- The causal direction of this association remains uncertain, necessitating robust methodologies to establish causality.
Purpose of the Study:
- To investigate the causal role of beta-carotene in the development of type 2 diabetes using a Mendelian randomization approach.
- To provide evidence for or against a direct causal effect of antioxidant vitamin beta-carotene on type 2 diabetes risk.
Main Methods:
- Utilized a common polymorphism (rs6564851) near the BCMO1 gene, a strong genetic instrument for circulating beta-carotene levels.
- Employed data from the InCHIANTI and ULSAM studies to estimate beta-carotene-diabetes associations and a triangulation approach with the DIAGRAM Consortium for Mendelian randomization analysis.
Main Results:
- Observational analyses in InCHIANTI and ULSAM studies showed an inverse association between beta-carotene levels and type 2 diabetes risk (OR 0.90 [0.86-0.95] and OR 0.90 [0.84-0.97], respectively).
- The Mendelian randomization analysis revealed no significant association between the BCMO1 polymorphism (rs6564851) and type 2 diabetes risk (OR 0.98 [0.93-1.04], p = 0.58).
- The estimated effect of the genetic variant on type 2 diabetes risk was smaller than expected based on its effect on beta-carotene levels and the observed association between beta-carotene and diabetes.
Conclusions:
- Findings from this Mendelian randomization study do not support a causal protective role for beta-carotene against type 2 diabetes.
- The results are consistent with randomized controlled trials, indicating that beta-carotene supplementation is unlikely to prevent type 2 diabetes.
Related Concept Videos
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...